CSPC Pharmaceutical Group Limited. Return on Equity

CSPC Pharmaceutical Group Limited. (CSPCY) currently reports a ROE of 25.03%. That is above the Healthcare sector average of 21.67%. Use the charts on this page to explore CSPC Pharmaceutical Group Limited.'s ROE history and peer comparisons.

CSPC Pharmaceutical Group Limited.'s ROE of 25.03% is higher than the Healthcare sector average of 21.67%. That is roughly 15.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but CSPC Pharmaceutical Group Limited.'s current 25.03% should be judged against Healthcare norms (sector average: 21.67%) and against CSPCY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 25.03%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.67%. From there, open related valuation or income-statement pages for CSPC Pharmaceutical Group Limited., and consider following CSPCY for alerts when major investors trade the stock.

CSPC Pharmaceutical Group Limited. is classified in the Healthcare sector. On ROE, it currently shows 25.03% versus a sector average near 21.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSPCY with unrelated industries.